Literature DB >> 10388666

Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions.

H Okamoto1, M Takahashi, T Nishizawa, M Ukita, M Fukuda, F Tsuda, Y Miyakawa, M Mayumi.   

Abstract

A nonenveloped, single-stranded, and circular DNA virus designated TT virus (TTV) has been reported in association with hepatitis of unknown etiology. TTV has a wide sequence divergence (approximately 52%), by which it is classified into at least 16 genotypes separated by an evolutionary distance of >0.30. Therefore, the detection of TTV DNA by polymerase chain reaction would be influenced by primers deduced from conserved or divergent regions of the genome. Of the 30 sera from healthy individuals, up to 17% tested positive with primers deduced from coding region, much less frequently than up to 93% testing positive with primers from noncoding region. These differences were not attributable to the sensitivity of detection, because a cloned TTV DNA of genotype 1a was detected sensitively (up to 1 copy per test) with primers deduced from either the coding or the noncoding region of the same genotype. Sera testing positive only with noncoding region primers, or those showing higher titers with noncoding than coding region primers, contained TTV DNA strains with sequence divergence of 47-53% from the TA278 isolate of genotype 1a within the N22 region spanning 222-231 nucleotides. Some of the sera contained two or three TTV DNA strains of distinct genotypes. These results indicate TTV strains with extremely high sequence divergence prevailing in healthy individuals and frequent mixed infection with TTV strains of distinct genotypes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388666     DOI: 10.1006/viro.1999.9770

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  51 in total

1.  Extensive homologous recombination among widely divergent TT viruses.

Authors:  M Worobey
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  High frequencies of HGV and TTV infections in blood donors in Hangzhou.

Authors:  J Yan; L L Chen; Y H Luo; Y F Mao; M He
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  Sequestration of TT virus of restricted genotypes in peripheral blood mononuclear cells.

Authors:  H Okamoto; M Takahashi; N Kato; M Fukuda; A Tawara; S Fukuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Sequence heterogeneity of TT virus and closely related viruses.

Authors:  Y E Khudyakov; M E Cong; B Nichols; D Reed; X G Dou; S O Viazov; J Chang; M W Fried; I Williams; W Bower; S Lambert; M Purdy; M Roggendorf; H A Fields
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Nearly constant shedding of diverse enteric viruses by two healthy infants.

Authors:  Beatrix Kapusinszky; Philip Minor; Eric Delwart
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

7.  TT virus (TTV) genotyping in blood donors and multiple transfused patients in Brazil.

Authors:  Maria Fernanda de Castro Amarante; Simone Kashima; Dimas Tadeu Covas
Journal:  Virus Genes       Date:  2007-06-15       Impact factor: 2.332

8.  Torque teno virus infection in hemodialysis patients in North India.

Authors:  Mohammad Irshad; Kishore Mandal; Shiwani Singh; S K Agarwal
Journal:  Int Urol Nephrol       Date:  2009-09-24       Impact factor: 2.370

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

10.  TTV and HPV co-infection in cervical smears of patients with cervical lesions.

Authors:  Martina Saláková; Vratislav Nemecek; Ruth Tachezy
Journal:  BMC Infect Dis       Date:  2009-07-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.